HomeWomen's HealthAgingFDA issues proposed guidelines for developing drugs for Alzheimer’s disease

FDA issues proposed guidelines for developing drugs for Alzheimer’s disease

Author(s):

On Feb. 7, 2013, the U.S. Food and Drug Administration (FDA) issued a proposal designed to help companies developing new treatments for patients in the early stages of Alzheimer’s disease. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Couple talking to NP

Getting Covid Vaccine Won’t Hurt Pregnancy Chances; Getting Covid Could

Couples planning a pregnancy might be relieved to know that getting a Covid vaccine does not hurt their odds of conceiving, according to the...